Complicações clínicas da descompensação do diabetes mellitus tipo 1 em crianças
Authors:
- Tainá Rodrigues ToquetonTTTainá Rodrigues Toqueton
- Kleyton Matheus Honorato MunizKMKleyton Matheus Honorato Muniz
- Iara GarciaIGIara Garcia
- Silmara Fernandes de MeloSMSilmara Fernandes de Melo
- Délio Guerra Drummond JúniorDJDélio Guerra Drummond Júnior
- Thiago Marques LimaTLThiago Marques Lima
- Gabriella Giuliana Pereira Neto PegoloGPGabriella Giuliana Pereira Neto Pegolo
- Maria Fernanda Marques LimaMLMaria Fernanda Marques Lima
- Francisco Rodrigues Nascimento JuniorFJFrancisco Rodrigues Nascimento Junior
- Igor Costa SantosISIgor Costa Santos
Open Access
- 17 September 2023
- conference paper
- Published by Seven Events
Abstract
O Diabetes Mellitus tipo 1 (DM1) é uma doença metabólica crônica que afeta predominantemente crianças e jovens, resultando na destruição das células produtoras de insulina no pâncreas. A falta de insulina leva ao aumento dos níveis de glicose no sangue, o que pode causar descompensações e levar a complicações clínicas graves. DOI:http://doi.org/10.56238/IICongressmedicalnursing-025Keywords
This publication has 16 references indexed in Scilit:
- Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetesActa Diabetologica, 2020
- The rate of hyperglycemia and ketosis with insulin degludec‐based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trialsPediatric Diabetes, 2019
- Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trialPediatric Diabetes, 2018
- LRBA deficiency with autoimmunity and early onset chronic erosive polyarthritisClinical Immunology, 2016
- Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene MutationJournal of Clinical Immunology, 2016
- Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetesPediatric Diabetes, 2015
- Sick day management in children and adolescents with diabetesPediatric Diabetes, 2014
- Assessment and monitoring of glycemic control in children and adolescents with diabetesPediatric Diabetes, 2014
- The delivery of ambulatory diabetes care to children and adolescents with diabetesPediatric Diabetes, 2014
- Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes MellitusDiabetes Therapy, 2014